World News | Israeli Startup's Personalised Cell Therapy Gets FDA Fast-track Designation

BioGenCell receives FDA Fast Track Designation for BGC101, a personalized cell therapy for severe Critical Limb Threatening Ischemia (CLTI), using its TRACT platform to regenerate damaged tissue.